|Abbott Laboratories, of Abbott Park, Ill.||ID Now COVID-19 test||Molecular point-of-care test delivers positive results in as little as 5 minutes and negative results in 13 minutes; based on isothermal nucleic acid amplification technology; will run on the company's ID Now platform||For the detection of nucleic acid from SARS-CoV-2||Received emergency use authorization from the U.S. FDA|
|Battelle Memorial Institute, of Columbus, Ohio||Critical Care Decontamination System||Capable of decontaminating up to 80,000 respirator masks per system each day using concentrated, vapor phase hydrogen peroxide; can decontaminate the same respirator mask up to 20 times without degrading the mask's performance||Eliminates biological contaminates, including SARS-CoV-2, on personal protective equipment||Received emergency use authorization from the U.S. FDA|
|Electrocore Inc., of
Basking Ridge, N.J.
|Gammacore Sapphire||Noninvasive, hand-held medical therapy applied at the neck as an adjunctive therapy||Treats migraine and cluster headache through the utilization of a mild electrical stimulation to the vagus nerve that passes through the skin||Received expanded 510(k) clearance from the U.S. FDA to include the prevention of migraine in adult patients|
|Ossdsign AB, of Uppsala, Sweden||Ossdsign Cranial PSI||3D-printed implant for bone regeneration||For cranial reconstruction||Received approval from the Japanese Pharmaceuticals and Medical Devices Agency|
|Zoll Medical Corp., of Chelmsford, Mass.||Zoll Therox system||Provides Supersaturated Oxygen (SSO2) Therapy, which delivers hyperbaric levels of oxygen directly to the damaged heart muscle immediately after successful revascularization via angioplasty and stenting of the blocked coronary artery||Reduces heart muscle damage following left anterior descending ST-elevation myocardial infarction||Received U.S. FDA approval for second-generation system|
For more information about individual companies and/or products, see Cortellis.